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Summary  Congenital  pseudarthrosis  of  the  tibia  (CPT)  is  an  uncommon  disease  with  various
clinical presentations  ranging  from  simple  anterolateral  tibial  angulation  to  complete  non-union
with extensive  bone  defects.  Classiﬁcations  of  radiographic  ﬁndings  include  atrophic  or  hyper-
trophic pseudarthosis  as  well  as  cystic  or  dystrophic  lesions.  Although  the  relationship  between
CPT and  type  1  neuroﬁbromatosis  is  well  known,  the  exact  pathogenesis  still  remains  unclear.
The ﬁbrous  soft  tissue  found  in  the  pseudarthosis  and  the  abnormal  periosteum  are  certainly  a
key to  the  pathology,  possibly  due  to  decreased  osteogenic  capacities  and  impaired  local  vascu-
larization.  Treatment  of  CPT  is  still  challenging  in  pediatric  orthopedics  because  of  bone  union
difﬁculties,  persistant  angulation,  joint  stiffness  and  sometimes  severe  limb  length  discrepancy
sequellae.  Numerous  treatments  based  on  biological  and/or  mechanical  concepts,  surgical  or
not, have  been  reported  with  variable  success  rates.  Vascularized  ﬁbular  grafts  and  the  Ilizarov
technique have  greatly  transformed  the  prognosis  of  CPT.  Despite  these  steps  forward,  repeated
surgical  procedures  are  often  necessary  to  obtain  bone  union  and  the  risk  of  amputation  is  never
entirely eliminated.  The  effectiveness  of  new  treatments  (bone  morphogenetic  protein,  bone
marrow stromal  cell  grafts,  pulsed  electromagnetic  ﬁelds,  induced  membrane  technique.  .  .)
still requires  to  be  conﬁrmed.  Combining  these  new  techniques  with  existing  treatments  may
improve the  ﬁnal  prognosis  of  CPT,  which  nevertheless  remains  poor.
© 2011  Elsevier  Masson  SAS.  All  rights  reserved.
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f  all  the  diseases  in  children,  congenital  pseudarthrosis  of
he  tibia  (CPT)  is  probably  one  of  the  most  difﬁcult  to  treat.
ven  today,  failure  to  obtain  bone  union  is  frequent  and  the
unctional  prognosis  is  mediocre  because  of  residual  defor-
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oi:10.1016/j.otsr.2011.09.001ities,  joint  stiffness  and  remaining  length  inequalities.  The
im  of  surgical  treatment  is  to  achieve  bone  union  of  the
seudarthrosis  while  restoring  alignment  in  the  leg  to  pre-
ent  the  risk  of  recurrent  fracture  and  to  preserve  function
nd  bone  growth  in  the  leg.
CPT  is  a  rare  disease  in  children,  with  an  estimated  fre-
uency  of  1/150,000  births.  It  can  be  deﬁned  as  a  disorder  of
he  diaphysis  which  is  revealed  by  either  pseudarthrosis  at
irth  or  by  a  pathological  fracture  presenting  in  bone  with
odiﬁcations  such  as  bowing,  narrowing  of  the  medullary
anal  or  a  cyst.  Although  its  relationship  with  type  1
served.
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neuroﬁbromatosis  (NF1)  or  von  Recklinghausen’s  disease  was
conﬁrmed  in  1950  [1],  the  physiopathology  of  CPT  has  still
not  been  clearly  deﬁned.  This  disease  has  many  presenta-
tions,  both  clinical  and  radiographic.
Numerous  mechanical  and/or  biological  based
approaches  have  been  described  in  the  literature  to
treat  this  disease  with  success  rates  that  vary.  The  progno-
sis  of  CPT  has  changed  considerably  in  the  last  few  decades
thanks  to  vascularized  ﬁbular  transfers  and  the  Ilizarov
technique.  Despite  these  advances,  several  operations  are
often  necessary  to  obtain  union  of  the  pseudarthrosis,  and
the  risk  of  amputation  is  never  entirely  eliminated.
Discovery and clinical diagnosis
Bowing  may  be  discovered  during  a  clinical  examination  at
birth  or  in  the  ﬁrst  weeks  in  life  which  presents  as  bowing  of
the  tibia  convex  anterolaterally  or  a  discontinuity  between
the  two  bones  of  the  tibial  segment  [2].  Severe  neonatal
forms  or  primary  pseudarthrosis,  in  which  signs  are  present
at  birth,  can  be  distinguished  from  secondary  pseudarthro-
sis,  which  is  revealed  by  a  pathological  fracture  when  the
child  begins  walking  [3].  The  clinical  presentation  varies
considerably,  from  simple  bowing  to  various  extensive  bone
deformities  causing  more  or  less  severe  bowing  in  one  or
two  bones  of  the  leg,  and  which  may  result  in  a  pathological
fracture  and  pseudarthrosis  (Fig.  1).  Severity  of  shortening
in  the  leg  also  varies.
Normally  CPT  is  unilateral,  located  at  the  junction  of  the
middle  and  distal  thirds  of  the  tibial  segment  with  no  pre-
dominance  for  sex  or  side.  The  ﬁbula  is  also  affected  in  more
than  half  the  cases.  A  complete  clinical  examination,  in  par-
ticular  neurological  and  dermatological,  associated  with  an
investigation  of  the  family  history  must  be  performed  in
the  presence  of  limb  anomalies  in  a  newborn  or  an  infant
[2]  to  differentiate  a  diagnosis  of  isolated  CPT  from  one
o
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Figure  1  Clinical  (A)  and  radiographic  (B)  heterogeneity  of  congen
of the  leg  and  atrophic  pseudarthrosis  of  the  lower  third  of  the  leg  (751
f the  bone  anomalies  associated  with  NF1.  The  latter  is
 multisystemic  neurocutaneous  disease  with  an  autosomal
ominant  pattern  and  an  estimated  frequency  of  1/4000
irths.  The  diagnosis  of  NF1  is  clinical,  based  on  a  series
f  criteria  deﬁned  at  the  1987  consensus  conference  [4].
hese  bone  abnormalities  correspond  to  primary  dystrophic
one  lesions,  or  are  secondary  to  damage  to  the  soft  tissues,
hich  affect  bone  growth.  While  the  incidence  of  bowing
nd  CPT  is  less  than  4%  in  NF1  [5,6], half  of  the  patients
40—80%)  presenting  with  CPT  are  NF1  carriers  [5,7].
maging
tandard  X-rays  show  heterogeneous  lesions  from  simple
onvex  anterolateral  bowing  to  true  tibial  discontinuity,
ith  an  image  of  resorption  of  the  two  ends  of  the  fracture
esponsible  for  signiﬁcant  loss  of  bone  substance.
Cystic  forms  are  also  found,  in  which  bowing  appears  at
etween  6  weeks  and  1  year.  The  cortices  are  continuous
nd  condensed  and  thickened  in  the  concave  part  of  the
urvature.  The  medullary  canal  is  narrow  and  an  image  of  a
yst  can  be  seen  at  the  apex  of  the  curvature.  The  deformity
radually  worsens  until  the  cortex  ﬁnally  breaks,  causing  a
ransverse  fracture  [8].  In  dysplasic  forms,  the  bowing  is
isible  at  birth  and  sometimes  pseudarthrosis  may  already
e  present.  The  tibia  is  narrow  with  an  hourglass  appear-
nce  and  the  medullary  cavity  is  partially  or  completely
bstructed.  The  ﬁbula  is  frequently  affected  in  these  types.
hen  pseudarthrosis  has  developed,  the  ends  of  the  bone
ay  be  thin,  atrophic  or  on  the  other  hand,  wide  and  hyper-
rophic.  These  radiological  features  deﬁne  a certain  number
f  criteria  which  are  the  basis  of  the  different  classiﬁcations
f  CPT.
The  recent  development  of  magnetic  resonance  imaging
MRI)  will  provide  more  detailed  analysis  of  both  bone  and
specially  soft  tissue  lesions,  in  particular  the  periosteum
ital  pseudarthrosis  of  the  tibia  (CPT)  with  anterolateral  bowing
C).
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•igure  2  Pseudarthrosis  of  the  distal  quarter  of  the  ﬁbula  w
1-weighted  sequences  of  the  area  of  pseudarthrosis  and  the  th
round  the  pseudarthrosis  [9]  (Fig.  2).  New  bone  perfu-
ion  sequences  can  show  bone  vascularization  defects,  help
eﬁne  the  limits  of  resection  and  increase  understanding  of
he  physiopathological  mechanisms  of  this  disease.
lassiﬁcation
umerous  classiﬁcations  have  been  described,  which  is  a
ign  of  the  heterogeneity  of  this  disease  and  the  difﬁculty
f  including  the  etiology,  natural  history  and  treatment  in
ne  classiﬁcation  [10]. Among  these  we  can  mention:
 the  Crawford  classiﬁcation  [7],  which  is  the  most  fre-
quently  used  today  (Fig.  3).  This  classiﬁcation  has  the
advantage  of  being  descriptive  and  identifying  the  dif-
ferent  stages  as  CPT  progresses:
◦  type  I:  anterior  bowing  with  an  increase  in  cortical  den-
sity  and  a  narrow  medulla;
◦  type  II:  anterior  bowing  with  narrow,  sclerotic  medulla,
◦  type  III:  anterior  bowing  associated  with  a  cyst  or  signs
of  a  prefracture,
◦  type  IV:  anterior  bowing  and  a  clear  fracture  with  pseu-
darthrosis  often  associating  the  tibia  and  ﬁbula;
 the  Boyd  classiﬁcation  [11]  with  6  types,  which  has  prog-
nostic  value:
◦  type  I:  anterior  bowing  associated  with  other  congenital
malformations,
◦ type  II:  anterior  bowing  with  an  hourglass  appearance
to  the  tibia.  A  fracture  usually  occurs  before  the  age
of  2.  The  ends  of  the  bone  are  thin,  rounded  and  scle-
rotic  with  obliteration  of  the  intramedullary  canal.  This
type  is  more  often  associated  with  NF1  and  there  is  a
poor  prognosis  with  frequent  recurrence  during  bone
growth,
g
i
i cystic  appearance  (A)  MRI  features  (B,  C)  with  an  isosignal  on
ned  periosteum.
◦ type  III:  pseudarthrosis  developing  from  an  intraosseous
cyst,  usually  at  the  middle  and  distal  third  junction.
Anterior  bowing  can  precede  or  follow  the  development
of  the  fracture.  This  type  has  a  high  rate  of  union  and
recurrence  is  rare,
◦  type  IV:  sclerotic  bone  with  no  pathological  bowing.  The
medullary  canal  is  partially  or  completely  obliterated.
A  fatigue  fracture  may  occur  and  progress  to  pseu-
darthrosis.  The  prognosis  is  good  if  treatment  begins
before  the  fatigue  fracture  occurs,
◦  type  V:  dyplasic  appearance  to  the  ﬁbula.  Pseudarthro-
sis  can  be  located  on  either  of  the  two  bones  of  the
tibial  segment.  The  prognosis  is  good  if  the  lesion  is
located  only  on  the  ﬁbula,  extension  to  the  tibia  has  a
prognosis  similar  to  type  II,
◦  type  VI:  associated  with  an  intraosseous  ﬁbroma  or  a
schwannoma.  The  prognosis  depends  on  the  aggressiv-
ity  of  the  intraosseous  lesion.
Apoil  2  stage  classiﬁcation  [3]  (Fig.  4):
◦ type  I:  atrophic  pseudarthrosis  with  thin  bone  ends.  The
ends  of  the  bone  are  said  to  look  like  ‘‘barley  sugar’’,
which  results  in  a  more  or  less  signiﬁcant  long-term  loss
of  bone  substance,  or  overlap.  The  inferior  fragment  is
often  small  and  aplasic,  ending  in  an  atrophic  epiphysis.
There  is  no  medullary  canal.  The  ﬁbula  has  an  identical
lesion,
◦  type  II:  tight,  extensive  hypertrophic  pseudarthrosis.
The  bone  ends  are  dense,  wide  and  the  medullary  canal
has  disappeared,  the  cortex  thickens  on  the  concave
side.  The  ﬁbula  is  often  bowed  and  abnormally  shaped.The  limitation  of  all  these  classiﬁcations  is  disease  pro-
ression  and  the  possible  passage  from  one  stage  to  another
n  the  classiﬁcation  in  the  same  patient  as  he  grows  making
t  difﬁcults  to  analyse  the  series  in  the  literature.
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Anatomical pathology
Histological  studies  show  that  there  is  a  marked  cuff  of
ﬁbrous  tissue  in  the  area  of  pseudarthrosis,  also  called
the  ﬁbrous  hamartoma  [12], in  continuity  with  abnormal
periosteal  thickening  [13]. Most  of  the  cells  of  this  hamar-
toma  have  been  identiﬁed  as  ﬁbroblasts  [14]. A  certain
quantity  of  ﬁbrocartilage  and  hyalin  cartilage  [15]  is  also
associated  with  the  ﬁbrous  tissue  as  well  as  several  areas
of  endochondral  ossiﬁcation.  Resorption  lacuna  with  giant
osteoclasts  are  present  at  the  pseudarthrosis-bone  junction
[16].  This  osteolytic  component  seems  to  be  more  marked  in
young  children  and  decreases  with  growth,  then  disappears
at  skeletal  maturity  [11]. All  of  these  phenomena  are  a  sign
of  a  bone  remodeling  defect  [12]  which  is  responsible  for
T
m
p
Figure  4  Atrophic  (A)  and  hypertrophford  classiﬁcation.
he  sclerotic,  hourglass  appearance  of  the  bone  adjacent  to
he  pseudarthrosis  as  well  as  the  atrophy  of  the  bone  ends
16].  Localized  growth  of  this  ﬁbrous  tissue,  associated  with
xcess  bone  resportion  participates  in  the  development  of
ystic  intracortical  lesions,  deformity  and  sclerosis  in  mixed
ypes  of  CPT  [16]. The  composition  of  the  pseudarthrotic
issue  seems  to  be  identical  whether  or  not  it  is  associated
ith  NF1  [16].
hysiopathologyhe  etiology  of  CPT  is  still  a  subject  of  debate.  Numerous
echanical,  vascular  or  genetic  theories  have  been  pro-
osed  in  the  literature.  None  of  them  provide  an  entirely
ic  (B)  CPT  (JP  Damsin  collection).
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t54  
atisfying  explanation  for  the  pathogenesis  of  CPT  or  its  loca-
ion,  probably  because  of  the  heterogeneity  of  the  disease
nd  its  inconsistent  association  with  NF1.
The  key  role  of  the  ﬁbrous  hamartoma  and  of  the  patho-
ogical  periosteum  has  been  extensively  described  in  the
tiology  of  CPT.  They  are  said  to  prevent  union  by  a  mechan-
cal  effect  of  interposition  and  be  responsible  for  defective
ascularisation  in  the  bone.  The  periosteum  could  create  a
brous  band  causing  an  increase  in  local  pressure  around
he  bone  resulting  in  reduced  vascularization  as  well  as
one  atrophy  [14]. The  vascularlization  defect  could  also
e  secondary  to  thickening  of  the  vessel  walls  in  the  area  of
seudarthrosis  [13].
The  association  of  NF1  in  40  to  80%  [5]  of  the  cases  of  CPT
uggests  a  genetic  cause.  NF1  codes  for  a  ubiquitous  pro-
ein,  neuroﬁbromin,  whose  functions  include  the  negative
egulation  of  Ras,  a  protein  involved  in  cell  differentiation
nd  proliferation  [5].  In  its  normal  state,  neuroﬁbromin  pos-
esses  a  role  of  tumor  suppressor,  by  converting  Ras-GPT  into
n  inactive  form  of  Ras-GDP.  The  mutation  of  NF1  results  in
 loss  of  neuroﬁbromin  activity  resulting  in  the  maintenance
f  the  active  form  of  Ras  [5].  In  certain  cases  of  CPT  associ-
ted  with  NF1,  a  double  activation  of  the  NF1  gene  was  found
n  pseudarthrotic  tissue  [17]. This  genetic  anomaly  was  not
ound  in  all  cases  and  cannot  explain  alone  the  pathogene-
is  of  CPT  [15,18].  The  loss  of  function  of  neuroﬁbromin  can
esult  in  a  Ras-MAPK  pathway  anomaly  resulting  in  defec-
ive  osteoblastic  differentiation.  Overexpression  of  the  Ras
athway  can  also  result  in  an  increase  in  osteoclast  activ-
ty  and  their  precursors,  explaining  bone  resporption  in  CPT
12]  and  the  high  rate  of  recurrent  fractures.
In  case  of  NF1,  the  absence  of  nerve  cells  in  the  pseu-
arthrotic  tissue  suggests  that  the  bone  abnormalities  in
F1  correspond  to  primary  bone  dysplasia  [15,19].  The  phys-
opathology  of  CPT  could  therefore  be  identical,  whether
r  not  it  is  associated  with  NF1,  especially  since  there  is
o  histological  difference  in  the  composition  of  the  ﬁbrous
amartoma.  The  physiopathology  of  CPT  probably  involves
he  various  different  hypotheses,  with  signal  anomalies
ausing  increased  osteoclast  activity  associated  with  an
steoblastic  differentiation  anomaly  resulting  in  a  bone-
emodeling  defect,  which  is  also  favored  by  the  decrease
n  local  vascularization.
rognostic factors
he  general  factors  are:
 the  association  with  NF1  was  long  considered  to  be  a neg-
ative  predictive  factor  for  bone  union  in  CPT  [20]. Today,
results  in  the  literature  do  not  support  this  notion  with
comparable  rates  of  union  in  these  groups  [10];
age  is  certainly  an  important  factor  with  a  better  progno-
sis  when  the  disease  is  not  markedly  progressive  and  the
fracture  occurs  later.The  local  factors  are:
 the  site  of  pseudarthrosis:  a  lower  location,  in  the  infe-
rior  metaphysis,  makes  it  difﬁcult  to  control  the  distal
i
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fragment.  The  necessity  of  including  the  ankle  and  hind
foot  in  ﬁxation  may  result  in  articular  sequellae.
 the  type  of  pseudarthrosis  is  an  important  parameter:
severe  deformities  with  bone  atrophy,  extensive  scle-
rotic  lesions  with  a  small  diameter  bone  and  signiﬁcant
shortening  have  a  poor  prognosis  [21]. Associated  ﬁbular
involvement  seems  to  worsen  the  prognosis  [22].
 lower  limb  length  discrepancies:  can  be  caused  by  bone
from  not  applying  weight  and  stimulating  growth  or  be
linked  to  the  anglulation  and  overlap  of  bone  ends  [8].
esponse  to  treatment
he  surgical  history  and  remaining  bone  capital  are  impor-
ant  prognostic  factors,  in  particular  the  number  of  surgical
nterventions  and  the  persistence  of  marked  angulation
avoring  recurrent  fractures.  The  resorption  rate  of  the  graft
ay  also  have  a  poor  prognosis.
ethods of treatment
reatment  of  CPT  is  surgical,  as  the  natural  progression  of
PT  is  towards  worsening,  deformity  and  shortening  [2].
earing  a  protective  brace  before  the  child  has  begun  walk-
ng  delays  the  moment  of  the  fracture  in  case  of  bowing  or
imits  the  deformity  in  case  of  conﬁrmed  pseudarthrosis.
The  aims  of  surgical  treatment  are  not  only  limited  to
nion  of  CPT.  It  must  also  restore  satisfactory  alignment  of
he  leg  to  prevent  the  risk  of  recurrent  fracture  and  limit
eg  length  discrepancies  while  preserving  articular  function.
inally,  clinical  and  radiological  union  of  the  area  of  pseu-
arthrosis  is  only  a  criteria  for  real  cure  when  correction  is
aintained  after  growth  is  complete  [3].
The  three  surgical  techniques,  which  are  tradition-
lly  described  as  achieving  the  best  rates  of  union  are
ntramedullary  nailing  associated  with  a  bone  graft,  vascu-
arized  ﬁbular  transfer  and  the  Ilizarov  technique.  We  will
rst  present  these  three  techniques  before  describing  new
merging  surgical  and/or  biological  techniques.
ntramedullary  nailing  associated  with  a  bone  graft
irst  described  in  1956  by  Charnley  [23], the  principle  is
ased  on  resection  of  areas  of  pseudarthosis  associated  with
table  intramedullary  ﬁxation  and  transfer  of  a large  graft
hat  may  or  may  not  be  supported  by  the  ﬁbula  (Fig.  5).
ntramedullary  ﬁxation  results  in  alignment,  correction  of
he  deformity  and  guides  bone  lengthening  during  growth.
ifferent  types  of  ﬁxation  are  used  depending  on  the  surgi-
al  teams.  The  use  of  a  telescopic  nail  or  pins  helps  protect
he  reconstructed  area  during  growth  and  avoids  having  to
hange  the  internal  ﬁxation.  In  case  of  distal  pseudarthrosis
r  small  bone  fragments,  stable  ﬁxation  is  obtained  by  talo-
alcaneal  and  tibiotalar  joint  bridging  with  material  inserted
y  transplantal  approach.  Associated  intrameduallary  ﬁxa-
ion  of  the  ﬁbula  reinforces  the  stability  if  ﬁxation  is  located
n  area  of  the  pseudarthrosis  or  stabilizes  an  osteotomy  for
hortening.
The  rate  of  union  with  this  technique  varies  greatly  in  the
iterature  from  28%  [24]  to  more  than  80%  [25]  probably  in
Congenital  pseudarthrosis  of  the  tibia  755
Figure  5  AP  view  X-ray  of  Crawford  stage  IV  congenital  pseudarthrosis  of  the  tibia  (CPT)  (A).  Union  after  an  intertibioﬁbular  graft
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relation  to  the  technique,  the  ﬁxation  used  and  an  associ-
ated  ﬁbular  procedure.  All  recent  publications  report  a  rate
of  union  of  more  than  80%  [26,27].
The  negative  points  of  intramedullary  nailing  with  a  bone
graft  are  the  frequent  need  to  bridge  the  ankle  and  the  hind-
foot  resulting  in  pain  and  stiffness.  Release  of  the  ankle  after
union  of  the  pseudarthrosis  only  slightly  increases  range  of
motion  in  the  ankle  [25]. Pes  cavus  and/or  valgus  ankle  can
develop  during  growth.  This  technique  also  results  in  resid-
ual  leg  length  discrepancies  in  more  than  half  the  cases
[26].
Vascularized  bone  transfers
Since  it  was  described  in  1978  by  Judet  and  Gilbert  [28]  in
the  treatment  of  CPT,  free  ﬁbular  transfer  has  been  exten-
sively  used  for  this  indication.  The  principle  is  based  on
wide  resection  of  the  dystrophic  tibia,  which  is  replaced  by
healthy  vascularized  bone.  Hypertrophy  of  the  bone  trans-
fer  is  then  observed  in  response  to  mechanical  stimulation.
Classically,  the  vascularized  bone  was  transferred  from  the
controlateral  ﬁbula.  The  use  of  the  homolateral  ﬁbula  has
also  been  described  [29]. To  avoid  the  gradual  valgus  defor-
mity  of  the  ankle  in  young  children,  temporary  or  deﬁnitive
distal  metaphyseal  tibioﬁbular  fusion  can  be  performed.
There  are  numerous  types  of  graft  ﬁxation  and  a  stable
system  is  essential  for  union.  If  possible  the  ﬁbula  is  force-
fully  inserted  into  the  tibial  diaphysis  for  primary  stability.
Screwing  or  pinning  can  be  associated  at  each  end  for  rein-
forcement.  An  external  unilateral  or  circular  ﬁxator  can  also
be  associated  to  increase  stability  of  the  system  [30], so
that  walking  can  begun  again  and  to  reduce  the  risk  of  early
recurrence  (Fig.  6).
The  results  of  multicenter  studies  [21,31,32]  show  that
the  rate  of  primary  union  of  vascularized  transfers  is  more
f
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A and  proﬁle  (C)  views.  (JP  Padovani  collection).
han  70%  [32]  with  a  success  rate  that  increases  with  the
atient’s  age.
The  negative  points  of  vascularized  ﬁbular  transfer
re  the  frequent  necessity  of  a  2nd  graft  at  the  bone-
bular  junction  to  obtain  union  of  the  pseudarthrosis.
 second  operation  is  necessary  in  more  than  30%  of
ases.  The  risk  of  recurrent  fracture  is  high,  usually  at
he  bone-ﬁbular  junction  or  in  the  body  of  the  ﬁbular
raft  before  hypertrophy  [33]. This  technique  is  also  the
ource  of  residual  angulation,  occurring  in  more  than  half
he  cases  in  particular  valgus  and  recurvatum  deformi-
ies,  which  do  not  resolve  during  growth.  Valgus  ankle
eformities  on  the  side  of  the  harvested  ﬁbula  in  grow-
ng  children  may  cause  chronic  pain  to  develop  later  on
34].
lizarov  technique
lizarov  was  the  ﬁrst  to  use  his  ﬁxation  technique  in  CPT
35].  The  external  circular  ﬁxation  makes  it  possible  to  use
any  combinations,  which  can  be  adapted  to  the  type  of
seudarthrosis  [36]. Small  bone  fragments  can  be  stabilized
ith  this  technique,  a  residual  deformity  can  gradually  be
estored,  and  length  discrepancies  in  the  affected  limb  can
e  treated  during  the  same  surgical  procedure.  The  exter-
al  ﬁxation  can  be  extended  to  the  foot  depending  on  the
natomical  form  of  pseudarthrosis.
The  Ilizarov  method  involves  direct  compression  of
he  area  of  pseudarthrosis  with  or  without  resection.
epending  on  the  amount  of  loss  of  bone  substance,
he  area  of  bone  is  compressed  or  diaphyseal  trans-
er  is  performed  (Fig.  7).  In  the  latter  case,  epiphyseal
istraction  [36]  or  proximal  metaphyseal  corticotomy
s  performed  at  a  distance  from  the  dystrophic  area.
 bone  graft  in  the  form  of  a  simple  graft  or  an
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(igure  6  Double  barrelled  vascularized  ﬁbular  transfer  using
xation and  an  intramedullary  pin  for  the  ﬁbula  AP(A)  and  proﬁl
C). (A.  Hamel  Collection).
ntertibioﬁbular  graft  may  be  performed  during  the
ame  procedure  or  in  a  second  step  to  reinforce  union
37].
The  rate  of  union  varies  from  between  50  and  90%
38].  The  study  performed  by  the  European  Paediatric
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igure  7  AP  view  X-ray  of  Crawford  stage  IV  Congenital  pseudarthro
xation, bone  transfer  and  compression  of  the  area  of  pseudarthrosis  
C). (JP  Damsin  Collecion). contralateral  ﬁbula  associated  with  circular  external  Ilizarov
views.  Appearance  after  union  and  ablation  of  external  ﬁxation
rthopaedic  Society  (EPOS)  [24]  in  108  patients  treated
y  the  Ilizarov  method  shows  that  the  best  results  were
btained  with  resection  of  the  areas  of  pseudarthrosis  with
ompression  of  the  affected  area  and  metaphyseal  length-
ning  with  a  system  that  included  the  foot.
sis  of  the  tibia  (CPT)  (A).  Ilizarov  technique  with  intramedullary
(B).  Appearance  after  union  and  ablation  of  the  external  ﬁxation
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The  negative  points  of  the  Ilizarov  method  are  the  high
rate  of  recurrent  fractures,  linked  to  persistent  axial  defor-
mities  and  pin  infections.  A  second  intervention  is  necessary
in  nearly  half  the  cases  to  correct  a  residual  angular  defor-
mity,  to  treat  a  recurrent  fracture  or  an  infection.  A  valgus
ankle  deformity  was  found  in  25%  of  the  cases  because  of
persistent  ﬁbular  pseudarthrosis  or  a  distal  tibial  epiphy-
seal  growth  defect.  Associating  internal  ﬁxation  with  pins
or  telescopic  nails  with  the  external  ﬁxation  has  been  pro-
posed  because  of  the  high  rate  of  recurrent  fracture  and
axial  deformities  [37,39].
Osteoinducive  proteins  or  « bone  morphogenetic
proteins  »
The  role  of  bone  morphogenetic  proteins  (BMPs)  in  fracture
union  has  been  extensively  studied  in  the  literature  [40]. By
analogy  with  post-traumatic  pseudarthrosis  in  adults,  cer-
tain  authors  used  BMPs  in  the  treatment  of  CPT.  At  present,
the  use  in  children  is  limited  because  of  the  lack  of  informa-
tion  about  the  long-term  risks  in  immature  skeletons  [41],
in  particular  the  possibility  of  deleterious  results  on  growth
and  a  potential  tumor-inducive  effect.  Nevertheless,  there
is  ongoing  clinical  research  on  the  use  of  BMP’s  in  the  spe-
ciﬁc  case  of  pediatric  diseases,  in  particular  CPT  [42]. Two
recombinant  human  osteogenic  proteins  (RhBMP)  have  been
described  for  this  indication  in  children,  RhBMP-7  (OP-1® or
Osigraft®)  [43—47]  and  RhBMP-2  (Inductos®)  [41]. The  differ-
ent  surgical  techniques  used,  the  types  of  pseudarthrosis,
the  association  of  allo-  or  autografts  and  the  few  number
of  cases,  makes  it  difﬁcult  to  analyze  results.  The  choice
of  BMP  must  also  be  evaluated.  Physiologically,  BMP-2  acts
earlier  on  the  proliferation  and  differentiation  of  mesenchy-
mous  cells  into  chondroblasts  while  BMP-7  acts  on  osteoblast
differentiation.
A  French  national  PHRC  study  on  the  evaluation  of
rhBMP-2  in  association  with  classic  surgical  treatment  was
s
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Figure  8  AP  view  X-ray  of  Crawford  stage  IV  CPT  (A).  Placement  
cement spacer  and  autologous  graft  (C).  Appearance  after  union  (D)757
erformed  in  2007.  A  prospective  randomized  multicenter
tudy  was  performed  (EPOPEE  study),  to  deﬁne  the  efﬁcacy
f  Inductos® as  adjuvant  treatment  in  CPT.
nduced  membrane  and  spongy  autologous  graft
his  technique  was  developed  by  A.C.  Masquelet  for  the
reatment  of  infected  pseudarthroses  of  the  leg  [48]  and
iaphyseal  bone  defects  in  the  limbs  [49]. The  principle  is
ased  on  inducing  a  pseudosynovial  membrane  by  insert-
ng  a  cement  spacer  in  the  ﬁrst  stage  of  surgery,  which
lls  the  defect  to  be  reconstructed  associated  with  stable
nternal  ﬁxation.  Reconstruction  is  possible  in  the  second
tage  by  a  spongy  autologous  graft  after  the  cement  spacer
as  been  removed.  The  pseudosynovial  membrane  creates
 true  biological  chamber.  High  concentrations  of  endothe-
ial  and  osteoinducive  cell  growth  factors  including  BMP-2
ere  identiﬁed  in  the  cells  of  the  membrane  [50]. Besides
his  biological  role,  the  induced  membrane  and  the  cement
pacer  saves  space  for  diaphyseal  reconstruction.
Its  application  in  the  treatment  of  CPT  includes  com-
lete  resection  of  diseased  bone  and  ﬁbrous  tissue,  stable
ntramedullary  ﬁxation  and  a cement  spacer  [51]  (Fig.  8).
he  replacement  of  the  ﬁbrous  hamartoma  and  of  the  dis-
ased  periosteum  by  a  vascularized  membrane  producing
ascular  and  osteoinducive  cell  growth  factors  associated
ith  stable  ﬁxation  makes  it  possible  to  respond  to  most  of
he  existing  hypotheses  on  the  physiopathology  of  CTP.
eriosteal  grafts
aley  [52]  recently  described  a technique  using  a  free
eriosteal  graft  harvested  from  the  iliac  wing,  based  on  the
ource  of  osteoprogenitor  cells  contained  in  the  periosteum.
his  technique  involves  complete  resection  of  the  diseased
eriosteum  around  the  area  of  pseudarthrosis,  which  is
eplaced  with  a  periosteal  graft  which  covers  the  resected
of  a  cement  spacer  pressing  on  the  ﬁbula  (B).  Ablation  of  the
.
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rea  after  placement  of  a  bone  graft  and  intramedullary
ibular  and  ﬁbular  internal  ﬁxation  associated  with  an  exter-
al  Ilizarov  ﬁxator  [53].
lectrostimulation
ts  use  in  CPT  was  developed  in  the  1980’s  for  linear  pseu-
arthroses  or  with  bone  defects  of  less  than  5  mm,  then  it
as  nearly  completely  abandoned.  The  rate  of  union  was
pproximately  70%  [54]. Treatment  by  pulsed  electromag-
etic  ﬁelds  is  now  being  developed  in  the  treatment  of
seudarthroses  and  delayed  union  of  fractures  in  adults  with
ood  results.  Its  efﬁcacy  must  be  evaluated  in  the  treatment
f  CPT.
utologous  and  bone  marrow  grafts
he  capacity  for  osteogenic  differentiation  of  mesenchymal
tem  cells  has  been  used  in  adults  to  treat  femoral  head
ecrosis  and  pseudarthrosis,  in  particular  of  the  tibia  [55].
everal  cases  of  bone  marrow  grafting  have  been  reported  in
he  treatment  of  CPT  associated  with  traditional  treatment
56].  The  capacity  of  bone  marrow  cells  to  differentiate  into
steoblastic  cell  lines  could  be  enough  to  justify  its  use  in
he  treatment  of  CPT.  [57].
iscussion, therapeutic indications
he  superiority  of  one  treatment  over  another  remains  difﬁ-
ult  to  determine.  The  many  different  clinical  presentations
f  CPT,  the  lack  of  differentiation  between  NF1  and  non
F1  patients,  the  effect  of  prior  treatment,  the  necessity
f  having  a  follow-up  that  is  long  enough  and  until  skeletal
aturity,  the  age  at  surgery  and  the  few  number  of  cases  in
ach  series  make  comparison  of  treatments  and  evaluation
f  results  difﬁcult.  The  most  recent  series  show  comparable
ates  of  union  for  the  3  main  techniques.
In  the  multicenter  study  performed  by  the  EPOS  in  2000
n  340  patients  [24], the  Ilizarov  technique  was  shown  to
e  the  best  surgical  technique  because  of  stable  ﬁxation
ith  circular  rings  and  preservation  of  alignment  and  length
y  the  lengthening  created  by  bone  segment  transport.  A
ulticenter  series  performed  in  Japan  in  2005  in  73  cases
21],  found  that  the  best  results  were  obtained  with  the
llizarov  technique  and  vascularized  ﬁbular  transfers.  The
oor  results  obtained  with  intramedullary  nailing  in  these
eries  were  related  to  a  greater  variability  in  surgical  tech-
ique,  ﬁxation  with  the  ankle  and  systematic  use  or  not  of
 graft.  This  surgical  technique  is  probably  more  accessible
han  the  two  others  and  success  certainly  depends  upon  the
urgeon’s  experience.
Although  the  best  treatment  for  CPT  remains  controver-
ial,  there  is  a  consensus  on  a  certain  number  of  points  in
he  literature.  Whatever  the  technique  used,  realignment
f  the  tibial  segment  and  stable  internal  ﬁxation  are  essen-
ial  for  union.  Intramedullary  ﬁxation  is  the  best  technique
o  maintain  alignment  during  growth  and  prevent  the  risk  of
ecurrent  fracture.  The  association  of  an  intramedullary  nail
ith  the  Illizarov  technique  is  now  being  developed  [58].
lthough  the  risk  of  infection  is  increased,  this  approach
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ncreases  stability,  preserves  long-term  alignment  and/or
uides  lengthening.  The  rate  of  recurrent  fracture  is  reduced
n  more  than  50%  of  cases  [52]  in  particular  during  abla-
ion  of  the  external  ﬁxator.  Intramedullary  ﬁxation  is  more
ifﬁcult  with  vascularized  ﬁbular  transfer  because  of  the
isk  of  injury  to  the  vascularized  transplant.  Axial  deformi-
ies,  which  are  a  source  of  recurrent  fracture,  cannot  be
revented  with  external  ﬁxation.
The  role  of  ﬁbular  surgery  has  probably  been  under-
stimated  in  the  literature.  Indeed,  persistent  ﬁbular
seudarthrosis  favors  valgus  ankle  and  can  explain  the  high
ate  of  recurrent  fractures  some  time  after  primary  union
26]. For  many  authors,  treatment  of  the  ﬁbula  is  system-
tic  in  case  of  pseudarthrosis.  Fibular  union  associated  or  not
ith  internal  ﬁxation  by  intramedullary  nailing  reinforces
tability  by  distributing  loads  and  protects,  in  particular,
rom  rotational  trauma  [26,36].  If  continuity  is  preserved  or
f  the  ﬁbula  is  the  site  of  hypoplasia  or  bowing,  the  choice
f  treatment  is  more  debatable.  Some  authors  do  not  inter-
ene  [59], others  perform  fusion  by  intertibioﬁbular  graft
fter  tibial  union  [25]. Finally  for  certain  [27], osteotomy  to
horten  the  ﬁbula  is  necessary  for  realignment.  This  mainly
erves  to  prevent  distraction  of  the  area  of  tibial  pseu-
arthrosis  by  favoring  the  contact  of  the  two  bone  ends  and
heir  union.
If  stable  ﬁxation  is  essential  for  union,  what  role  does
esection  of  the  ﬁbrous  hamartoma  and  of  the  associated
iseased  periosteum  play?  At  present  these  elements  seem
o  be  the  key  elements  in  the  physiopathology  of  this  dis-
ase.  Although  this  resection  is  indispensable  for  numerous
uthors  [21,24]  it  increases  instability,  in  particular  of  the
istal  fragment.  Resection  can  be  ‘‘cancerologic’’  by  remov-
ng  sclerotic  bone,  interpositioned  tissue  and  the  diseased
eriosteum  or  be  limited  to  the  ﬁbrous  hamartoma  and  the
clerotic  bone.  It  is  difﬁcult  to  deﬁne  the  effect  of  the
xtent  of  resection  on  results,  because  this  variable  is  not
learly  described  in  the  literature.  At  present  the  extent
f  resection  is  determined  by  the  surgeon  during  surgery
y  macroscopic  evaluation  of  the  bone  and  the  reappear-
nce  of  a  permeable  intramedullary  canal.  MRI  could  play  an
mportant  role  in  the  preoperative  evaluation  of  the  ﬁbrous
amartoma,  the  periosteum  and  bone  lesions  to  improve
dentiﬁcation  of  the  extent  of  bone  and  and  soft  tissue
esions  to  be  excised.
Indications  for  surgery  should  take  into  account  the
hild’s  family  situation,  his/her  age,  the  type  and  loca-
ion  of  pseudarthrosis  as  well  as  the  surgical  history.  EPOS
24]  recommends  surgical  management  in  children  after  the
ge  of  3  because  of  the  difﬁculty  of  stabilizing  small  bone
ragments  in  younger  children.  These  mechanical  difﬁcul-
ies  are  also  supported  by  the  biological  notions  found  in
he  studies  by  Boyd  [11]  who  showed  that  osteolytic  activ-
ty  in  the  area  of  pseudarthrosis  was  more  important  in  the
oung  child.  The  best  results  were  obtained  with  the  Ilizarov
echnique  in  children  over  4  to  5  years  old  in  most  series
60],  or  between  6  and  9  years  old  for  EPOS  [24]. The  best
esults  were  obtained  with  vascularized  transfers  in  children
etween  3.5  and  7.5  years  old  [31]. Certain  authors  who
ecommend  intramedullary  nailing  with  bone  grafts  suggest
arly  surgery  in  children  under  the  age  of  3  and  obtain  bet-
er  fusion  rates  and  especially  less  affect  on  growth  [10,61].
or  others  [20,27],  age  does  not  affect  the  chances  of  union.
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iCongenital  pseudarthrosis  of  the  tibia  
It  is  certain  that  early  surgery  avoids  hypoplasia  of  the  leg
and  foot,  muscular  atrophy  and  increased  risk  of  leg  length
discrepancies  but  this  can  also  pose  technical  problems  in
young  children.  Successful  union  seems  to  be  inﬂuenced
more  by  the  type  of  pseudarthrosis  and  the  choice  of  surgical
technique  than  by  the  age  at  surgery.
At  present,  there  is  no  gold  standard  surgical  technique
to  successfully  treat  all  types  and  presentations  of  CPT.  The
choice  of  technique  should  be  adapted  to  the  type  of  pseu-
darthrosis  and  especially  to  the  extent  of  the  bone  defects.
In  normo-  and  hypertrophic  types,  when  there  is  little  short-
ening,  good  results  can  be  obtained  with  intramedullary
nailing  with  a  bone  graft  or  the  Ilizarov  technique  [60]. The
debate  usually  involves  atrophic  forms  in  which  resection
results  in  signiﬁcant  loss  of  bone  substance.  The  vascular-
ized  ﬁbula  and  the  Ilizarov  method  with  bone  transport  play
an  important  role  in  this  indication.  Transfer  of  healthy  vas-
cularized  bone  in  the  ﬁrst  case,  and  increasing  blood  ﬂow
by  proximal  corticotomy  and  diaphyseal  transfer  [36]  in  the
second,  creates  a  favorable  vascular  environment  for  union
while  compensating  for  bone  defects.  The  induced  mem-
brane  technique  is  also  appropriate  for  this  indication  by
creating  a  biological  chamber  with  osteogenic  and  vascu-
lar  growth  factors  while  ﬁlling  large  volume  bone  defects.
If  bone  substance  loss  is  no  more  than  4  cm,  these  three
techniques  can  be  used  depending  on  the  experience  of  the
surgical  team.  Beyond  this  or  in  case  of  extensive  sclerotic
forms  which  make  diaphyseal  transport  impossible,  a  vas-
cularized  graft  which  would  ﬁll  bone  defects  and  result  in
faster  union,  or  the  induced  membrane  technique,  can  be
considered.
The  efﬁcacy  of  treatments  that  can  be  called
‘‘complementary  to  traditional  surgery’’,  must  be  deter-
mined.  The  addition  of  BMPs  or  bone  marrow  cells  during
initial  surgery  or  secondarily  could  help  improve  and/or
accelerate  union  in  particular  at  the  graft/healthy  bone
junction.  It  is  clear  that  these  treatments  are  only  comple-
mentary  and  do  not  replace  stable  ﬁxation  and  vasularized
or  non-vascularized  bone  grafts.  The  role  of  pulsed  elec-
tromagnetic  therapy,  which  is  easy  to  administer  with
existing  portable  devices,  must  still  be  determined  in  the
management  of  CPT.
A protection  or  a  Sarmiento  type  brace  to  be  worn  sys-
tematically  by  the  child  is  recommended  by  most  teams
once  union  is  obtained  for  protection,  in  particular  in  case
of  residual  axial  deviation  or  fragile  union.
Finally  long-term  monitoring  is  necessary  until  the
patient  reaches  skeletal  maturity  to  evaluate  the  results  of
each  method  in  the  treatment  of  CPT.  Johnston’s  postoper-
ative  method  of  evaluation  [27]  could  be  used  for  objective
comparison  of  results  of  different  series.  This  includes:
• stage  1,  clear  union  with  full  normal  function  during  full
weight-bearing;
• stage  2,  incomplete  union  with  useful  function  but  a pro-
tective  brace  is  needed;  X-rays  show  a  transverse  cortical
or  longitudinal  defect  and/or  frontal  or  sagittal  deformity
of  more  than  15◦ which  may  or  may  not  be  associated  with
shortening  of  more  than  3  cm;
•  stage  3,  with  persistent  pseudarthrosis  or  a  recurrent  frac-
ture.
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equellae and complications
algus  ankle  is  frequent,  and  found  in  nearly  45%  of  cases
62],  linked  to  proximal  migration  of  the  lateral  malle-
lus.  This  causes  valgus  tibiotarsal  instability,  increasing
tress  on  the  lateral  side  of  the  tibial  epiphysis  and  caus-
ng  asymmetric  growth.  This  deformity  can  be  corrected
y  epiphysiodesis  of  the  medial  malleolus  by  stapling  or
ercutaneous  screws  [5],  which  is  simpler  than  a  supramalle-
lar  osteotomy  which  can  progress  to  pseudarthrosis.  Ankle
tiffness  develops  because  of  the  necessity  of  rigid  immobi-
ization  during  treatment  or  transplantation  and  may  cause
ain  or  foot  deformities,  in  particular  in  the  arch  because
f  upright  positioning  of  the  calcaneus.
Leg  length  discrepancies  are  also  a  frequent  problem.
hey  may  be  due  to  the  disease  itself  or  be  iatrogenic.
f  the  discrepancy  is  less  than  5  cm  it  can  be  treated  by
ontrolateral  epiphysiodesis.  If  there  is  a  signiﬁcant  discrep-
ncy,  the  Ilizarov  technique  is  indicated.  Lengthening  can  be
erformed  by  proximal  corticotomy  (as  long  as  the  bone  is
ormal  on  X-ray)  or  by  physeal  distraction,  but  there  is  a  risk
f  sterilizing  the  growth  cartilage.  Femoral  lengthening  has
lso  been  described  [25]  with  the  inherent  problem  of  knee
isplacement.
Recurrent  fractures  are  frequent  after  union.  They  can
ccur  early  as  long  as  the  medullary  canal  has  not  become
ermeable  again  and  can  be  prevented  in  part  by  a  protec-
ive  brace.  If  they  occur  after  primary  union  they  are  usually
 sign  of  persistent  axial  deviation.  The  initial  treatment  is
rthopedic  but  non-union  is  frequent  and  revision  surgery  is
hen  necessary.
Finally,  it  is  important  to  note  that  a  diagnosis  of
seudarthrosis  often  reveals  a  diagnosis  of  NF1.  These
atients  must  then  have  regular  follow-up  to  detect  other
omplications  which  they  are  at  risk  of  developing.
onclusion
PT  is  still  a  disease  whose  physiopathology  has  not  been
ompletely  clariﬁed.  The  key  elements  of  this  review  are
he  necessity  of  stable  ﬁxation,  which  is  essential  for  bone
nion,  and  restoration  of  anatomical  alignment.  Union  of
bular  pseudarthrosis  and  radical  resection  of  the  diseased
one  and  surrounding  tissue  are  certainly  important  ele-
ents.  The  development  of  preoperative  MRI  will  help
eﬁne  the  diseased  areas  to  be  resected.
Congenital  tibial  pseudarthrosis  is  a  severe  disease  whose
rognosis  is  uncertain  and  amputation  of  the  leg  can  never
e  completely  excluded.  There  is  no  surgical  technique  guar-
nteeing  permanent  primary  union  with  a  well-aligned  leg
nd  no  length  discrepancies  until  bone  growth  is  complete.
ew  emerging  techniques  combine  mechanical  and  biologi-
al  notions  associated  with  traditional  techniques  and  may
ecome  the  ideal  treatment,  but  this  must  to  be  validated
n  future  studies.isclosure of interest
he  author  declared  that  they  have  no  conﬂicts  of  interest
oncerning  this  article.
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